AptarGroup, Inc. ATR

CRYSTAL LAKE, Ill., September 14, 2026--Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

All three segments post growth with record quarterly revenue, but margin declines and operational challenges in beauty and closures temper the outlook.

Moby summary of AptarGroup, Inc.'s Q2 2026 earnings call

CRYSTAL LAKE, Ill., July 30, 2026--Aptar Reports Second Quarter 2026 Results

AptarGroup (ATR) recently reaffirmed its shareholder return policy by declaring a quarterly cash dividend of $0.48 per share, payable on August 20, 2026, to investors of record as of July 30. See our latest analysis for AptarGroup. AptarGroup’s recent dividend decision sits alongside a steady run in the stock, with a 30 day share price return of 5.87% and a year to date share price return of 8.84%, even as the 1 year total shareholder return declined 14.99% and the 3 year total shareholder...

AptarGroup stock is caught between two valuation signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from the current US$133.37 share price, while earnings-based multiples suggest the stock is trading on the expensive side and recent returns over the past year have been weak. Over the past 1 year, AptarGroup has delivered a return of 15.0% in the red, which raises questions about how much confidence the market currently has in the company at this...